Federal agencies are accelerating their workforce modernization efforts as hiring bottlenecks, skills shortages, and new federal talent initiatives expose the limitations of long-standing personnel ...

Comments from Nvidia (NVDA) at CES about next-generation chip cooling are prompting investors to reassess which companies stand to gain, or lose, as data-center infrastructure evolves, according to a ...

At CES 2026, amidst the spotlight on AI breakthroughs such as autonomous vehicles and humanoid robots, a crucial battle simmers quietly in the global AI data center (AIDC) industry. This competition ...

With digital penetration rising fast and electricity access still uneven, data centres could become unlikely catalysts for a brighter, resilient African power future. Although electrification has been ...

Lumentum Holdings Inc. recently disclosed that long-time finance leader Matthew Sepe plans to retire in fall 2026, with Eric Chang appointed as Chief Accounting Officer once the company files its ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. AI has become the driving force behind Europe’s digital ambitions. Across industries, from ...

In early January 2026, Ormat Technologies announced a 20-year Power Purchase Agreement with data center operator Switch, under which Switch will buy around 13MW of geothermal power from the upgraded ...

Global battery electric vehicle (BEV) sales rose 13% annually in 2024 to reach 10.4 million, accounting for 14% of new personal vehicle sales worldwide, according to the International Energy Agency ...

Correction: In a previous version of this article, Sand Springs, Oklahoma, was incorrectly identified as Sandy Springs in some photo captions, and Archbald, Pennsylvania, was incorrectly referred to ...

Africa stands at the cusp of a digital and energy transformation. As data centres expand across the continent, they are driving demand for reliable power, accelerating renewable integration, and ...

More than 90% of drugs that appear safe and effective in animal studies ultimately fail once they reach human trials, and the consequences are staggering: billions of dollars wasted, delays in new ...